Avalon Globocare Corp (NASDAQ: AVCO) is having an incredibly strong start to the trading session this morning after the company announced that it has achieved a breakthrough. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about:
- The breakthrough;
- what we’re seeing from AVCO stock as a result; and
- what we’ll be watching for ahead.
AVCO Announces Breakthrough
As mentioned above, Avalon GloboCare is having an incredibly strong start to the trading session this morning after announcing a breakthough. In a press release issued early this morning, the company said that it has identified novel human angiogenic exosomes/extracellular cellular vesicles derived from endothelial cells.
AVCO said that these angiogenic exosomes contain angiogenic factors developed to promote new blood vessel formation and tissue regeneration upon release from exosomes. The breakthrough will be presented at the upcoming Annual ISEV Meeting in Japan. The presentation is titled, “Novel Angiogenic Extracellular Vesicles Induced by StemReginin1.”
In a statement, David Jin, M.D., Ph.D., President and CEO at AVCO, had the following to offer:
Identification and isolation of tissue-specific exosomes is considered by many as the “Holy Grail” in this area. This discovery is essential for future development of endothelial cell-derived angiogenic exosomes in treating ischemic vascular diseases, as well as contribution to tissue and organ regeneration.
What We’re Seeing From The Stock
One of the first lessons that we learn when we start to work in the market is that the news leads to moves. When it comes to Avalon Globocare, the news proved to be overwhelmingly positive. After all, this breakthrough could lead to new assets that drive value for the company and its investors. So, it’s not surprising to see that excited investors are pushing the stock up in the market this morning. As is normally the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (9:51), AVCO is trading at $5.24 per share after a gain of $0.50 per share or 10.55% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on AVCO. In particular, we’re interested in following the story surrounding the company’s continued work to expand its pipeline and send the assets within its pipeline through the development process. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!